Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.52B | 16.37B | 15.97B | 12.10B | 10.69B | 10.72B |
Gross Profit | 6.79B | 6.73B | 7.10B | 7.84B | 8.54B | 6.04B |
EBITDA | 1.72B | 2.04B | 2.33B | 3.67B | 5.12B | 2.96B |
Net Income | 344.00M | 668.00M | 957.00M | 1.71B | 3.06B | 1.08B |
Balance Sheet | ||||||
Total Assets | 189.47B | 191.84B | 196.33B | 191.83B | 182.11B | 182.16B |
Cash, Cash Equivalents and Short-Term Investments | 29.36B | 29.30B | 26.66B | 31.21B | 38.45B | 45.31B |
Total Debt | 19.73B | 19.23B | 20.98B | 20.30B | 17.20B | 24.33B |
Total Liabilities | 174.93B | 177.93B | 182.63B | 178.97B | 165.06B | 167.46B |
Stockholders Equity | 14.55B | 13.90B | 13.70B | 12.86B | 17.05B | 14.70B |
Cash Flow | ||||||
Free Cash Flow | -252.00M | 1.07B | 1.80B | 2.71B | -1.08B | -581.00M |
Operating Cash Flow | 3.50B | 4.53B | 4.56B | 6.25B | 4.04B | 3.74B |
Investing Cash Flow | 4.17B | 4.99B | -7.18B | -17.26B | -11.10B | 8.43B |
Financing Cash Flow | -4.28B | -5.57B | 3.84B | 11.57B | -3.85B | 25.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $26.15B | 8.54 | 20.23% | 1.54% | -3.16% | 14.60% | |
75 Outperform | $30.78B | 52.38 | 8.80% | ― | 22.60% | ― | |
69 Neutral | $5.40B | 14.01 | 27.30% | ― | 12.63% | 149.03% | |
68 Neutral | $6.70B | 10.19 | 20.47% | 7.40% | 9.41% | 13.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $5.68B | 13.75 | 18.99% | 1.89% | -4.34% | -38.01% | |
51 Neutral | $11.96B | 25.24 | 4.18% | 3.03% | -5.33% | -32.99% |